Let us analyze each statement about enzyme inhibitor drugs:
This statement is correct. Enzyme inhibitors are commonly classified into competitive and noncompetitive inhibitors based on how they interact with enzymes.
This statement is correct. Inhibitors can bind to the active site or different sites called allosteric sites. Competitive inhibitors typically bind to the active site, while noncompetitive inhibitors bind to allosteric sites or other parts of the enzyme.
This statement is incorrect. Competitive inhibitors resemble the substrate and bind to the enzyme's active site to block substrate binding, not the allosteric site.
This statement is also incorrect. Noncompetitive inhibitors typically bind to an enzyme at a site other than the active site and do not block substrate binding directly. Instead, they inhibit enzyme activity by altering the enzyme's shape or function.
Based on this analysis, the correct statements are (A) and (B) only, making the correct answer:
By understanding the mechanisms of inhibition, we see that competitive inhibitors occupy the active site while noncompetitive inhibitors act elsewhere, altering enzyme activity.